000 02011cam  2200421zi 4500
0019.866188
003CaOODSP
00520221107162003
006m     o  d f      
007cr cn|||||||||
008181218t20192019onc     o    f000 0 eng d
020 |a9780660290362
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH169-10/2019E-PDF
24500|aQuestions and answers : |bprescription opioids ‐ sticker and handout requirements for pharmacists and practitioners.
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2019.
264 4|c©2019
300 |a1 online resource (12 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Foire aux questions : opioïdes sur ordonnance ‐ exigences relatives à l'autocollant et à la fiche de renseignements pour les pharmaciens et les praticiens.
500 |aCover title.
500 |a"Date: 2019/02/07."
500 |a"Publication date: February 2019."
500 |a"Pub.: 180653."
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references.
520 |a"This document provides guidance on the regulatory requirements specified in Part C, Division 1 of the Food and Drug Regulations regarding prescription labelling requirements for opioid drugs identified in Part A of the List of Opioids"--Introduction, page 6.
69207|2gccst|aPrescription drugs
69207|2gccst|aDrug labelling
7101 |aCanada. |bHealth Canada.
77508|tFoire aux questions : |w(CaOODSP)9.866190
795 |tQuestions and answers |w(CaOODSP)9.854773
85640|qPDF|s261 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H169-10-2019-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/policies/opioids-questions-answers.html